Claudia Bossen

3.3k total citations
20 papers, 2.2k citations indexed

About

Claudia Bossen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Claudia Bossen has authored 20 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Claudia Bossen's work include T-cell and B-cell Immunology (9 papers), Genomics and Chromatin Dynamics (5 papers) and NF-κB Signaling Pathways (4 papers). Claudia Bossen is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Genomics and Chromatin Dynamics (5 papers) and NF-κB Signaling Pathways (4 papers). Claudia Bossen collaborates with scholars based in United States, Switzerland and Germany. Claudia Bossen's co-authors include Pascal Schneider, Cornelis Murre, Robert Månsson, Aubry Tardivel, Jürg Tschopp, Elodie Belnoue, Christine Ambrose, Olivier Gaide, Sylvie Hertig and Jean-Luc Bodmer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Claudia Bossen

17 papers receiving 2.2k citations

Peers

Countries citing papers authored by Claudia Bossen

Since Specialization

Citations

This map shows the geographic impact of Claudia Bossen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Bossen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Bossen more than expected).

Fields of papers citing papers by Claudia Bossen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Bossen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Bossen. The network helps show where Claudia Bossen may publish in the future.

Co-authorship network of co-authors of Claudia Bossen

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Bossen. A scholar is included among the top collaborators of Claudia Bossen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Bossen. Claudia Bossen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials 2025 ·Cancer Research Communications ·Benjamin Solomon, Daniel S.W. Tan, Gilberto de Castro, Manuel Cobo, Marina Chiara Garassino, Jun Zhang, Bruce E. Johnson, Jay M. Lee, Pilar Garrido, Anton Buter, Marc R. Pelletier, Alexander Savchenko, Lexiang Ji, Jan C. Brase, Rafael Caparica, David Demanse, (unknown), Claudia Bossen, Tony Mok	1
2	Defining Non–small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data 2025 ·Cancer Research Communications ·Lang Ho Lee, (unknown), (unknown), Fanying Tang, Lauren Fairchild, Lexiang Ji, Angelo L. Grauel, Joel P. Wagner, Sebastian Szpakowski, Marc R. Pelletier, Lisa Kattenhorn, Laurent Sansregret, Carlotta Costa, Claudia Bossen, Heather Burks, Anna F. Farago, (unknown)	0
3	CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC 2025 ·JTO Clinical and Research Reports ·Jay M. Lee, Jean-Louis Pujol, Jun Zhang, (unknown), Masahiro Tsuboi, Edward S. Kim, Calvin S.H. Ng, Nicolás Moreno‐Mata, Amy L. Cummings, İlhan Hacıbekiroğlu, Abidin Şehitoğulları, Nirmal K. Veeramachaneni, Cathy Spillane, (unknown), Claudia Bossen, Alexander Savchenko, Chiara Lobetti‐Bodoni, Tony Mok, Pilar Garrido	0
4	Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints 2024 ·Statistics in Medicine ·Matthías Kormáksson, (unknown), David Demanse, Susanne Strohmaier, (unknown), (unknown), (unknown), Claudia Bossen, Achim Guettner, (unknown)	0
5	Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial 2023 ·Journal of Clinical Oncology ·Edward B. Garon, Shun Lü, Yasushi Goto, Pedro De Marchi, Luis Paz‐Ares, David R. Spigel, Michael Thomas, James Chih‐Hsin Yang, Andrea Ardizzoni, Fabrice Barlési, С. В. Орлов, Hiroshige Yoshioka, Giannis Mountzios, (unknown), Claudia Bossen, (unknown), Sabine Turri, Andrea P. Myers, Byoung Chul Cho	41
6	Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Andrés Caballero-Oteyza, Michele Proietti, Baerbel Keller, (unknown), (unknown), Matteo Pecoraro, Hermann Eibel, Klaus Warnatz, Esteban Ballestar, Roger Geiger, Claudia Bossen, Bodo Grimbacher	5
7	Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2018 ·Nucleic Acids Research ·(unknown), (unknown), Markus Hildenbeutel, (unknown), Maximilian Müller, Claudia Bossen, Sven Diederichs, Tatjana I. Cornu, Toni Cathomen, Claudio Mussolino	67
8	The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth 2015 ·Nature Immunology ·Claudia Bossen, (unknown), Aaron N. Chang, Robert Månsson, Hans-Reimer Rodewald, Cornelis Murre	97
9	Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate 2012 ·Nature Immunology ·Yin C. Lin, Christopher Benner, Robert Månsson, Sven Heinz, Kazuko Miyazaki, Masaki Miyazaki, Vivek Chandra, Claudia Bossen, Christopher K. Glass, Cornelis Murre	213
10	Chromatin Topology and the Regulation of Antigen Receptor Assembly 2012 ·Annual Review of Immunology ·Claudia Bossen, Robert Månsson, Cornelis Murre	71
11	CTCF-binding elements mediate control of V(D)J recombination 2011 ·Nature ·Chunguang Guo, Hye Suk Yoon, Andrew Franklin, Suvi Jain, Anja Ebert, Hwei-Ling Cheng, Erica Hansen, Orion Despo, Claudia Bossen, Christian Vettermann, Jamie Bates, (unknown), Darienne R. Myers, Harin Patel, Michael P. Gallagher, Mark S. Schlissel, Cornelis Murre, Meinrad Busslinger, Cosmas Giallourakis, Frederick W. Alt	200
12	CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells 2011 ·Proceedings of the National Academy of Sciences ·Stephanie C. Degner, Jiyoti Verma‐Gaur, (unknown), Claudia Bossen, G. Michael Iverson, Ali Torkamani, Christian Vettermann, Yin C. Lin, Zhongliang Ju, Danae Schulz, (unknown), Barbara K. Birshtein, Nicholas J. Schork, Mark S. Schlissel, Roy Riblet, Cornelis Murre, Ann J. Feeney	170
13	Transcription and recombination factories: common features? 2010 ·Current Opinion in Cell Biology ·Joseph Lucas, Claudia Bossen, Cornelis Murre	27
14	Mutation of the BAFF furin cleavage site impairs B‐cell homeostasis and antibody responses 2010 ·European Journal of Immunology ·Claudia Bossen, Aubry Tardivel, Laure Willen, Carrie A. Fletcher, Mai Perroud, Friedrich Beermann, Antonius Rolink, Martin Scott, Fabienne Mackay, Pascal Schneider	50
15	APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells 2008 ·Blood ·Elodie Belnoue, Maria Pihlgren, Tracy L. McGaha, Chantal Tougne, Anne-Françoise Rochat, Claudia Bossen, Pascal Schneider, Bertrand Huard, Paul‐Henri Lambert, Claire-Anne Siegrist	266
16	TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts 2007 ·Blood ·Claudia Bossen, Teresa G. Cachero, Aubry Tardivel, (unknown), Laure Willen, Max Dobles, Martin Scott, (unknown), Elodie Belnoue, Claire‐Anne Siegrist, Stéphane Chevrier, Hans Acha‐Orbea, Helen Leung, Fabienne Mackay, Jürg Tschopp, Pascal Schneider	226
17	Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human 2006 ·Journal of Biological Chemistry ·Claudia Bossen, (unknown), Aubry Tardivel, Jean-Luc Bodmer, Olivier Gaide, Sylvie Hertig, Christine Ambrose, Jürg Tschopp, Pascal Schneider	346
18	BAFF, APRIL and their receptors: Structure, function and signaling 2006 ·Seminars in Immunology ·Claudia Bossen, Pascal Schneider	404
19	Investigation and molecular mimicry of the antigen involved in the interaction between the monoclonal antibody 5D10 and the human breast cancer cell line MCF‐7 2006 ·Biotechnology and Bioengineering ·Caroline Vandevyver, (unknown), Claudia Bossen, Igor Fisch, (unknown), J. Raus, Ruth Freitag	3
20	Formation of Virus-like Clusters Is an Intrinsic Property of the Tumor Necrosis Factor Family Member BAFF (B Cell Activating Factor) 2006 ·Biochemistry ·Teresa G. Cachero, (unknown), Fang Qian, Eric S. Day, Claudia Bossen, (unknown), Aubry Tardivel, (unknown), John Eldredge, Laura Silvian, Alexey A. Lugovskoy, (unknown), Kathy Strauch, Pascal Schneider, Adrian Whitty	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact